slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 5,581-5,610
Pages 395
Rows per page 30
Slide function
5,581-5,610 of 11,828
32
Data presented as line charts showing percent change over time (weeks 4 and 8) for Ejection Function and Fractional Shortening.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
12
TTM = Trailing Twelve Months; ODR = Owner Direct Revenue (implied context).Limbach Holdings | Investor Presentation Deck | 25 slides · Limbach
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
09
The slide outlines a clear divestment strategy to generate liquidity.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Problem & Complication1 hit
17
Uses a visual metaphor of a lemon split into two colors to represent internal vs external sourcing.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Solution & Approach1 hit
18
Slide 18 of a pitch deck, focusing on operational infrastructure and efficiency gains.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Solution & Approach1 hit
19
The slide uses bar charts to show revenue growth for two distinct product segments.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Solution & Approach1 hit
20
The chart shows a significant jump in LTM 3Q22 revenue compared to previous years.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Evidence & Proof1 hit
26
Slide 26 of the deck.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
27
Includes a site plan map and architectural rendering.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Evidence & Proof1 hit
28
Limoneira | Investor Presentation Deck | 39 slidesLimoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Evidence & Proof1 hit
36
Limoneira | Investor Presentation Deck | 39 slidesLimoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
37
The slide uses a split-chart layout to show financial trends and operational guidance side-by-side.Limoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
38
Limoneira | Investor Presentation Deck | 39 slidesLimoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
14
The slide details the dosing regimens for different cohorts over induction and consolidation phases.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
15
The slide uses a process-flow diagram to present five key clinical findings.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
18
Each patient is represented by a timeline showing rapid decline in fungal load from screening to final visit day.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
19
Matinas BioPharma | Investor Presentation Deck | 31 slidesMatinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
25
The slide highlights clinical safety and pharmacokinetic success for an oral formulation of amikacin.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
26
Data presented as three distinct charts: line graph for weight, dot plot for congestion, and dot plot for viral titers.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
27
The slide highlights a $2.75M upfront payment and the strategic synergy between Matinas' LNC platform and BioNTech's mRNA expertise.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
09
The slide uses a mix of bullet points and checkmarks to categorize technical achievements and market opportunities.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations Loop · Voice Of Customer1 hit
13
The slide uses a before-after-bridge structure to demonstrate therapeutic efficacy.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
14
Includes longitudinal patient data and representative imaging.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
20
The slide displays two line charts comparing PAX-101 against placebo across multiple time points, with error bars indicating standard error.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
22
The slide uses a human-centric image to emphasize the clinical impact of the drug.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
07
The slide presents three dot plots comparing Vehicle, MPLA, PHAD, 3D PHAD, and 3D 6-Acyl PHAD treatments.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Zoom In1 hit
08
Includes three dot plots for bacterial clearance (Lung, Spleen, Kidney) and one Kaplan-Meier survival curve.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Zoom In1 hit
11
The slide uses a combination of line charts and bar charts to present clinical trial results.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
05
Includes detailed footnotes explaining the basis of the metrics and financial outlook.Skillsoft | Results Presentation Deck | 34 slides · Skillsoft
Pitch deck Investor relations Loop · Pattern Hunter1 hit
11
The chart illustrates the shift in ARR distribution from single-product customers to multi-product customers between 4Q19 and 4Q22.Skillsoft | Results Presentation Deck | 34 slides · Skillsoft
Pitch deck Investor relations Loop · Pattern Hunter1 hit